| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.089 | 0.06 |